SCHEMBL4001000

SCHEMBL4001000

CCC(CC)C(=O)N1CCC2(CC1)NCC(=O)N2Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 1/20 0.43
USP7 Q93009 1/20 0.41
CYP2D6 P10635 4/20 0.40
ALDH1A1 P00352 5/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RIPK1 Q13546 1/20 0.39
HSD17B10 Q99714 1/20 0.38
LMNA P02545 3/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
CHRM1 P11229 2/20 0.38
USP2 O75604 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800078 0.84 L3MBTL1 (0.38) L3MBTL1GAAUSP7ALDH1A1TSHR
SCHEMBL24106950 0.82 OPRD1 (0.46) GAACYP2D6ALDH1A1TSHRRIPK1
Simufilam SCHEMBL12627054 0.80 MC4R (0.46) GAAALDH1A1LMNAMAPK1MEN1
SCHEMBL1800769 0.80 CXCR3 (0.41) L3MBTL1GAAUSP7CYP2D6ALDH1A1
SCHEMBL2934997 0.80 CXCR3 (0.41) L3MBTL1GAAUSP7CYP2D6ALDH1A1
Simufilam SCHEMBL22361808 0.79 MC4R (0.45) GAAALDH1A1LMNAMAPK1MEN1
Simufilam SCHEMBL22361802 0.79 MC4R (0.45) GAAALDH1A1LMNAMAPK1MEN1
Hydrochloric Acid SCHEMBL1800156 0.79 CCR5 (0.41) L3MBTL1GAAUSP7CYP2D6ALDH1A1
SCHEMBL24106959 0.79 RIPK1 (0.39) CYP2D6ALDH1A1TSHRRIPK1LMNA
SCHEMBL12627087 0.79 OPRD1 (0.51) GAACYP2D6ALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP disclosed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO disclosed